SeraCare Life Sciences was awarded a seven-year commitment valued at $23.7 million to provide management and oversight of disease-study specimens for the NIAID Division of AIDS (DAIDS).
SeraCare will provide cataloging, processing, labeling, storage, and dispersal of specimens for DAIDS. The company will also provide technical support and training to NIH collaborators and investigators on issues related to specimen processing and handling.